ADMA Biologics Inc
NASDAQ:ADMA
ADMA Biologics Inc
NASDAQ:ADMA
Price:
9.485 USD
0.05%
Market Closed
Updated:
Jun 1, 2024
ADMA Biologics Inc
Net Issuance of Debt
|
ADMA Biologics Inc
Net Issuance of Debt Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADMA Biologics Inc
NASDAQ:ADMA
|
Net Issuance of Debt
-$23.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
$12.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
181%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$45.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
4%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADMA Biologics Inc's Net Issuance of Debt?
Net Issuance of Debt
-23.6m
USD
-23.6m
USD
Based on the financial report for Mar 31, 2024, ADMA Biologics Inc's Net Issuance of Debt amounts to -23.6m USD.
What is ADMA Biologics Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
-58 878%
-58 878%
Over the last year, the Net Issuance of Debt growth was -58 878%.
You don't have any saved screeners yet
